HLA-DR4 (HLA-DRA*0101/HLA-DRB1*0405,Balb/c)

Nomenclature

Balb/c-H2-Aaem1(HLA-DRA*0101)H2-Ab1em1(HLA-DRB1*0405)Smoc

Cat. NO.

NM-HU-264672

Strain State

Developing

Export PDF

Gene Summary

Gene Symbol
H2-Ab1

Synonyms

IAb; Ia2; Ia-2; Abeta; H-2Ab; H2-Ab; Rmcs1; I-Abeta

NCBI ID

14961

MGI ID

103070

Ensembl ID

ENSMUSG00000073421

Pubmed

H2-Ab1

Human Ortholog

HLA-DQB2

Model Description

This mouse model was obtained by further humanizing the H2-Ab1 gene through homologous recombination technology based on the existing strain hHLA-DRA*0101 (Balb/c) (NM-HU-263059), thereby creating a humanized mouse model with dual HLA-DRA*0101 and HLA-DRB1*0405 targets.

You may also like

Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more